Skip to main content

Fine Lines

1
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
1
Obagi® Saypha® MagIQ™ Injectable Hyaluronic AcidPhase 41 trial
Active Trials
NCT07421544Not Yet Recruiting100Est. Jul 2026
ReVision Therapeutics
ReVision TherapeuticsNJ - Ridgewood
3 programs
Anti-aging SerumN/A1 trial
Facial cleanserN/A1 trial
Gentle CleanserN/A1 trial
Active Trials
NCT05271136Completed26Est. Oct 2020
NCT04545970Completed56Est. Jul 2020
NCT06629792Completed32Est. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fitzpatrick CompanyObagi® Saypha® MagIQ™ Injectable Hyaluronic Acid
ReVision TherapeuticsGentle Cleanser
ReVision TherapeuticsAnti-aging Serum
ReVision TherapeuticsFacial cleanser

Clinical Trials (4)

Total enrollment: 214 patients across 4 trials

NCT07421544Fitzpatrick CompanyObagi® Saypha® MagIQ™ Injectable Hyaluronic Acid

Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

Start: Mar 2026Est. completion: Jul 2026100 patients
Phase 4Not Yet Recruiting

A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation

Start: Jan 2022Est. completion: May 202232 patients
N/ACompleted

A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum

Start: Sep 2020Est. completion: Oct 202026 patients
N/ACompleted

A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines

Start: Dec 2019Est. completion: Jul 202056 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.